Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
155.55
-2.51 (-1.59%)
At close: Mar 28, 2025, 4:00 PM
154.36
-1.19 (-0.77%)
Pre-market: Mar 31, 2025, 7:53 AM EDT
CRL Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for CRL stock have an average target of 193.08, with a low estimate of 151 and a high estimate of 250. The average target predicts an increase of 24.13% from the current stock price of 155.55.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CRL stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 10 | 9 | 9 | 11 | 11 | 13 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 2 | 2 | 1 |
Total | 14 | 13 | 13 | 15 | 15 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $190 → $170 | Strong Buy → Hold | Downgrades | $190 → $170 | +9.29% | Mar 21, 2025 |
Citigroup | Citigroup | Strong Sell → Hold Upgrades $155 → $175 | Strong Sell → Hold | Upgrades | $155 → $175 | +12.50% | Mar 4, 2025 |
JP Morgan | JP Morgan | Hold Maintains $175 → $165 | Hold | Maintains | $175 → $165 | +6.08% | Feb 20, 2025 |
Baird | Baird | Hold Maintains $177 → $173 | Hold | Maintains | $177 → $173 | +11.22% | Feb 20, 2025 |
Barclays | Barclays | Hold Maintains $166 → $160 | Hold | Maintains | $166 → $160 | +2.86% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
3.87B
from 4.05B
Decreased by -4.44%
Revenue Next Year
4.05B
from 3.87B
Increased by 4.65%
EPS This Year
9.46
from 0.20
Increased by 4,628.52%
EPS Next Year
10.43
from 9.46
Increased by 10.27%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.1B | 4.3B | 4.8B | ||
Avg | 3.9B | 4.1B | 4.3B | ||
Low | 3.7B | 3.9B | 4.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1.9% | 12.1% | 18.2% | ||
Avg | -4.4% | 4.7% | 6.6% | ||
Low | -8.7% | -0.3% | 0.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 9.96 | 12.96 | 12.94 | ||
Avg | 9.46 | 10.43 | 11.49 | ||
Low | 8.96 | 9.44 | 10.44 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4,882.3% | 37.0% | 24.0% | ||
Avg | 4,628.5% | 10.3% | 10.2% | ||
Low | 4,380.1% | -0.2% | 0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.